𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunohistochemical and clinical evaluation of cathepsin expression in soft tissue sarcomas

✍ Scribed by Peter Würl; Helge Taubert; Axel Meye; Temuujin Dansranjavin; Ekkehard Weber; Dagmar Günther; Dieter Berger; Hannelore Schmidt; Henning Dralle; Friedrich-Wilhelm Rath

Publisher
Springer
Year
1997
Tongue
English
Weight
554 KB
Volume
430
Category
Article
ISSN
1432-2307

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of intermediate filaments in
Expression of intermediate filaments in soft-tissue sarcomas
✍ M. Miettinen; V.-P. Lehto; R. A. Badley; I. Virtanen 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 French ⚖ 837 KB

## Abstract Monospecific antibodies and indirect immunofluorescence microscopy were used to investigate the presence of cytoskeletal intermediate filaments of the keratin, vimentin and desmin types in 43 soft‐tissue sarcomas. The results showed that vimentin was present in the neoplastic cells of a

Immunohistochemical detection of bone mo
Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas
✍ Hideki Yoshikawa; Wolfgang J. Rettig; Joseph M. Lane; Kunio Takaoka; Edward Alde 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 687 KB

Background. Bone morphogenetic proteins (BMPs) are potent inducers of bone formation. Functional and immunohistochemical studies have identified BMPs in a subset of osteosarcomas. In the present study, the authors extend the analysis of BMP expression to other bone and soft tissue sarcomas. Methods

Clinical importance of late recurrence i
Clinical importance of late recurrence in soft-tissue sarcomas
✍ Gibbs, John F.; Lee, R. Jeffrey; Driscoll, Deborah L.; McGrath, Brian E.; Mindel 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

Background and Objectives: Soft-tissue sarcomas (STS) represent a diverse histologic group of malignancies at risk for local and distant failure. We studied the impact of late (5 or more years) vs. early recurrence (less than 5 years) on subsequent outcome. Methods: Four hundred sixty-eight patients